Pharmacoeconomic evaluation of treatments for Poly Cystic Ovarian Syndrome (PCOS).

Masroor D, Khaliq SA, Ahmad SM, Mazhar F, Azhar I

Open source

DOI
10.1186/s12962-024-00569-6
Published
2024 Sep 5
Container
Cost effectiveness and resource allocation : C/E
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12962-024-00569-6,
  title = {Pharmacoeconomic evaluation of treatments for Poly Cystic Ovarian Syndrome (PCOS).},
  author = {Masroor D and Khaliq SA and Ahmad SM and Mazhar F and Azhar I},
  year = {2024},
  journal = {Cost effectiveness and resource allocation : C/E},
  doi = {10.1186/s12962-024-00569-6},
  url = {https://doi.org/10.1186/s12962-024-00569-6}
}

RIS

TY  - JOUR
TI  - Pharmacoeconomic evaluation of treatments for Poly Cystic Ovarian Syndrome (PCOS).
AU  - Masroor D
AU  - Khaliq SA
AU  - Ahmad SM
AU  - Mazhar F
AU  - Azhar I
PY  - 2024
JO  - Cost effectiveness and resource allocation : C/E
DO  - 10.1186/s12962-024-00569-6
UR  - https://doi.org/10.1186/s12962-024-00569-6
ER  - 

APA

D, M., SA, K., SM, A., F, M., & I, A. (2024). Pharmacoeconomic evaluation of treatments for Poly Cystic Ovarian Syndrome (PCOS).. Cost effectiveness and resource allocation : C/E. https://doi.org/10.1186/s12962-024-00569-6

Source records